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Two tetramethyl-substituted dispiro-1,2,4,5-tetraoxanes (7,8,15,16-tetraoxadispiro[5.2.5.2]-
hexadecanes) 3 and 4 were designed as metabolically stable analogues of the dimethyl-
substituted dispiro-1,2,4,5-tetraoxane prototype WR 148999 (2). For a positive control we
selected the sterically unhindered tetraoxane 5 (7,8,15,16-tetraoxadispiro[5.2.5.2]hexadecane),
devoid of any substituents. Tetraoxanes 3 and 4 were completely inactive in contrast to
tetraoxanes 2 and 5. We hypothesize that the two inactive tetraoxanes possess sufficient steric
hindrance about the tetraoxane ring due to the two additional axial methyl groups to prevent
their activation to presumed parasiticidal carbon radicals by inhibiting electron transfer from
heme or other iron(II) species. For each of the tetraoxanes 2-4, the tetraoxane and both
spirocyclohexyl rings are in a chair conformation and the bond lengths and angles are all quite
normal except for the C1-C2 bond which is slightly lengthened. Comparison of the modeled
and X-ray structures for tetraoxanes 2-5 reveals that molecular mechanics (MMX and MM3)
and 3-21G* calculations each gave accurate structural parameters such as bond lengths, bond
angles, and dihedral angles. In contrast, semiempirical methods such as AM1 gave poor results.
Introduction
The discovery of artemisinin (qinghaosu, 1), a natu-
rally occurring endoperoxide sesquiterpene lactone,1
initiated a substantial effort to elucidate its molecular
mechanism of action2 and to identify novel antimalarial
peroxides.3 Many synthetic 1,2,4-trioxanes have since
been prepared, some with promising antimalarial po-
tential.2 There is now considerable evidence that heme
or other iron(II) species are required for reductive
activation of these antimalarial peroxides into carbon
free radicals which are presumed to convey their para-
siticidal effects.2,4-8
Among the many synthetic antimalarial peroxides,
dispiro-1,2,4,5-tetraoxanes such as 2 (WR 148999) are
notable in that they differ considerably in structure from
artemisinin and are readily prepared in one step from
substituted cyclohexanones.9 Tetraoxane 2 possesses
antimalarial activity comparable to 110 but, like arte-
misinin,11 has poor oral antimalarial activity.12 We
attribute the low oral activity of 2 to inactivating hepatic
or gut metabolism.12 Therefore, we set out to identify a
metabolically stable analogue based on the hypothesis
that the tetraoxane peroxide bonds of 2 were the point
of metabolic attack. We envisioned that analogues of
tetraoxane 2 with greater steric bulk flanking the
peroxide oxygen atoms might serve this purpose.
Using tetraoxane 2 as a prototype, we designed target
dispiro-1,2,4,5-tetraoxanes (7,8,15,16-tetraoxadispiro-
[5.2.5.2]hexadecanes) bearing two additional methyl
groups (3, 4). For a positive control we selected the
sterically unhindered tetraoxane 5, devoid of any sub-
stituents. In this work, we also desired to unambigu-
ously identify the structures of tetraoxanes 2-4 by
X-ray crystallographic structural analysis, even though
NMR analysis provides strong evidence that tetraoxanes
formed from 2-substituted cyclohexanones, as exempli-
fied by tetraoxane 2, are formed exclusively as single
centrosymmetric isomers.13,14 Moreover, X-ray crystal-
lographic analysis would also allow us to test the
postulate13 that the spirocyclohexyl rings in tetraoxane
* To whom correspondence should be addressed. Tel: (402) 559-
5362. Fax: (402) 559-9543. E-mail: jvenners@unmc.edu.
† Heriot-Watt University.
§ University of Nebraska at Omaha.
# University of Nebraska Medical Center.
‡ Walter Reed Army Institute of Research.
1246 J. Med. Chem. 2000, 43, 1246-1249
10.1021/jm990530+ CCC: $19.00 © 2000 American Chemical Society
Published on Web 02/24/2000
3 exist in a spirocyclohexyl twist-boat conformation in
order to minimize steric repulsion between the methyl
groups and the peroxide oxygen lone pairs.
Results and Discussion
X-ray Crystallography. For each of the tetraoxanes
2-4, their respective molecular structures in the solid
state are ideally centrosymmetrical, with their point
group and crystallographic inversion centers coincident.
The bond lengths and angles observed for compounds
2-4 are all within normal ranges (see Table 1).
As predicted by NMR13 and our molecular modeling
experiments (vide infra), all rings in tetraoxane 2 are
in the chair form with the tetraoxane equatorial carbon
atom bearing equatorial methyl groups. In this struc-
tural arrangement, the two methyl groups are at the
greatest possible distance from the peroxide oxygen lone
pairs. For tetraoxane 3, the X-ray crystallographic data
reveal that both spirocyclohexylidene rings are in a
chair, rather than the previously predicted twist-boat
conformation,13 with the tetraoxane equatorial carbon
atoms at C1 and C1A bearing the four methyl groups
(Figure 1). The geminal methyl groups adopt well-
defined axial and equatorial positions with respect to
the cyclohexylidene ring.
Compound 4 exhibits structural features which are
generally similar to 2 (Figure 2). The methyl substitu-
ents at C2 and C6 are trans with respect to each other.
To obviate potentially destabilizing steric interactions
with the lone pairs on the distal ring oxygen atoms, the
C6 methyl group, which is located in an axial positon,
is directed away from the tetraoxane ring.
Least-squares fitting of the crystal structures of
tetraoxanes 2-4 to that of the unsubstituted compound
515 indicates that there is good agreement in the
positions of the tetraoxane ring atoms in each case
(weighted root-mean-squared (rms) deviations: 0.002,
0.017, and 0.005 Å, respectively). Conversely, since the
C-C bond linking the spiro carbon C1 to the substituted
carbon C2 shows a slight but significant lengthening
in each case when compared to 5 (Table 1), structural
deviations are more pronounced for the positons of the
cyclohexylidene ring atoms, particularly for compounds
3 and 4.
Molecular Modeling. In the initial molecular mod-
eling studies of these tetraoxanes, all of the isomers of
1,10-dimethyl-7,8,15,16-tetraoxadispiro[5.2.5.2]hexadec-
ane (2) were built using PCModel 4.0 and the molecular
mechanics method MMX. Considering planar represen-
tations of 2, two stereoisomers are possible, a cis-10
isomer and a trans-10 isomer, each of which has three
configurational isomers of center chirality (a pair of
enantiomers and a meso structure). Each configura-
tional isomer can give rise to four conformational
isomers considering only chair conformations of the
three six-membered rings of the dispiro system. The
lowest strain energy of the 24 isomers was that of
the meso-(t-10)-1,10-dimethyl-7,8,15,16-tetraoxadispiro-
[5.2.5.2]hexadecane in the configuration eventually
confirmed by the X-ray structure (vide supra).16 The
conformation of this modeled isomer also corresponded
to that reported by Groth15 for tetraoxane 5. All other
modeled tetraoxanes were subsequently built from this
modeled structure.
As shown for tetraoxane 2 (Table 1), comparison of
the modeled and X-ray structures for tetraoxanes 2-517
Table 1. Comparison of Modeled and X-ray Crystallographic
Structures for Tetraoxane 2
MMX MM3 3-21G* crystal
Bond Lengths (Å)
O1-O2 1.477 1.457 1.466 1.478
C1-O1 1.421 1.429 1.448 1.436
C1-O2A 1.420 1.429 1.448 1.430
C1-C2 1.551 1.535 1.530 1.542
C1-C6 1.545 1.530 1.518 1.518
Bond Angles (deg)
O1-C1-O2A 108.7 106.8 107.0 108.0
C1-O1-O2 109.2 107.7 107.9 107.2
C2-C1-C6 109.4 109.9 112.7 113.2
C1-C2-C3 111.2 110.9 108.8 110.3
C1-C6-C5 112.0 112.2 109.9 111.6
Dihedral Angles (deg)
C1-O1-O2-C1A -61.3 -65.2 -64.6 -64.2
O2-O1-C1-O2A 60.9 64.6 63.9 64.5
O1-C1-O2A-O1A -60.9 -64.6 -64.1 -64.7
O1-C1-C2-C3 176.4 177.9 -179.5 173.9
C5A-C6A-C1A-O2 -63.3 -64.0 -61.0 -65.8
C6A-C1A-O2-O1 -62.3 -58.4 -59.4 -60.4
O2-O1-C1-C6 -63.1 -59.2 -59.5 -60.9
O1-O2-C1A-C2A 177.1 179.9 177.2 175.7
O1-C1-C6-C5 -176.4 -175.6 -178.5 -171.6
O2-C1A-C2A-C3A 66.7 67.2 65.8 72.6
Figure 1. Solid-state structure of tetraoxane 3 (ORTEP27).
The non-hydrogen atoms are represented by 50% probability
ellipsoids and hydrogen atoms by spheres of arbitrary radius.
Figure 2. Solid-state structure of tetraoxane 4 (ORTEP27).
The non-hydrogen atoms are represented by 50% probability
ellipsoids and hydrogen atoms by spheres of arbitrary radius.
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reveals that molecular mechanics (MMX and MM3) and
3-21G* calculations gave accurate structural param-
eters such as bond lengths, bond angles, and dihedral
angles. MMFF94 calculations also produced reasonable
parameters with bond lengths between those of MMX
and MM3 and with dihedral angles very close to those
obtained with MMX. The MMFF94 bond angles tended
to match the higher values obtained with either MMX
or MM3. Since the MMFF94 results were intermediate
between MMX and MM3, they are not reported here. A
potential advantage of MM3 over MMX is that MM3 is
parametrized for peroxides,18 whereas MMX is not.19
Nonetheless, the MMX and MM3 tetraoxane structures
were very similar, although MMX gave better O-O
bond lengths and gave fewer atoms deviating more than
2.00 standard deviations from the matched atoms in the
crystal structure than did MM3. However, MM3 struc-
tures always gave the smaller rms deviations.
The early MMX studies indicated a high degree of
symmetry in these tetraoxanes that was substantiated
by the other calculations and by the X-ray data. The
brevity of Table 1 reflects this symmetry. Although
molecular mechanics methods predict greater symmetry
for each of the tetraoxanes than was apparent from the
X-ray data, the 3-21G* results better reflect the X-ray
data in the calculated values for the equatorial C1-O1
and axial C1-O2A bond lengths in tetraoxanes 3 and
4. In contrast, semiempirical methods such as AM1 gave
poor results (O-O bond length 1.298 Å). Shorter O-O
bond lengths (1.396 Å) also resulted from the more time-
intensive 6-31G* ab initio computations.
Antimalarial Activity. Notwithstanding any pos-
tulated increase in metabolic stability, tetraoxanes 3
and 4 were completely inactive in contrast to the
tetraoxane prototype 2 (Table 2).10 The completely
unsubstituted tetraoxane 5 was as potent as 2. With
the possible exception of tetraoxane 5, the very weak
in vitro antimalarial activity of tetraoxanes 3 and 4
provides no justification for additional experiments to
assess their metabolic stability or oral bioavailability.
We hypothesize that the two inactive tetraoxanes
possess sufficient steric hindrance about the tetraoxane
ring due to the two additional axial methyl groups to
prevent their activation to presumed parasiticidal car-
bon radicals by inhibiting electron transfer from heme
or other iron(II) species.2 This steric hindrance probably
precludes an energetically reasonable approach of these
inactive tetraoxanes to heme - the putative antima-
larial peroxide receptor.20,21 A similar argument was
recently put forth to account for the low antimalarial
activity of the tetraoxane derived from phenylacetalde-
hyde22 and for the complete loss of antimalarial activity
for two C-5A methyl-substituted trioxane analogues of
artemisinin.23
We note that steric hindrance affecting peroxide bond
accessibility is only one of the many possibly significant
factors influencing tetraoxane antimalarial activity. In
the rationalization of antimalarial data other consider-
ations such as stability of carbon radicals formed by
â-scission after the initial electron transfer to the
peroxide bond should also be considered. A clear delin-
eation of the influence of steric and electronic effects
and other physicochemical attributes of the tetraoxanes
on their antimalarial activity is clearly not entirely
possible. As a complementary exploration of SAR, iron-
(II) reactions of these and related tetraoxanes are
underway.
Experimental Section
Melting points are uncorrected. 1H (300 MHz) and 13C (75
MHz) NMR spectra were recorded on a Varian XL-300
spectrometer using CDCl3 as a solvent. All chemical shifts are
reported in parts per million (ppm) and are relative to internal
(CH3)4Si for 1H and CDCl3 (77.0 ppm) for 13C NMR. Micro-
analyses were performed by M-H-W Laboratories, Phoenix, AZ.
Vapor pressure osmometry MW analyses were performed by
Galbraith Laboratories, Knoxville, TN. Cyclohexanone and 2,2-
dimethyl- and 2,6-dimethylcyclohexanone were available from
Aldrich Chemical Co.
Tetraoxane Synthesis. The tetraoxanes were prepared by
acid-catalyzed peroxidation of the corresponding cyclohexanone
derivative and were isolated as single stereoisomers as indi-
cated by 13C NMR spectra which displayed only one peak for
the two identical spiro carbon atoms at 105-111 ppm. Tet-
raoxane 2 was prepared as previously described.10 Tetraoxanes
3 and 4 were prepared by a modified method developed by
McCullough et al. using 50% rather than 86% H2O2.9 Tetraox-
ane 5 was synthesized according to a modified method
developed by Bertrand et al. using 50% rather than 30%
H2O2.24 Although we encountered no difficulties in working
with these rather stable and friction-insensitive peroxide
compounds,25 routine precautions such as the use of shields
and fume hoods and the avoidance of metal salts should be
observed whenever possible.
1,1,10,10-Tetramethyl-7,8,15,16-tetraoxadispiro[5.2.5.2]-
hexadecane (3): yield, 26%; mp 161-162 °C (lit.9 mp 161-
163 °C); 1H NMR 1.04 (s, 12H), 1.37-1.73 (m, 12H), 2.32 (t,
J ) 6.2 Hz, 4H); 13C NMR 21.30, 22.37, 22.85, 25.58, 37.45,
39.01, 110.72.
1,5,10,14-Tetramethyl-7,8,15,16-tetraoxadispiro[5.2.5.2]-
hexadecane (4): yield, 18%; mp 164-165 °C dec (CH3CN);
1H NMR 1.04 (br s, 12H), 1.25-2.15 (m, 14H), 3.34 (br s, 2H);
13C NMR 13.76, 19.68, 28.73 (br s), 29.69 (br s), 31.26 (br s),
33.78 (br s), 110.78; VPO MW 274; calcd MW 284. Anal.
(C16H28O4) C, H.
7,8,15,16-Tetraoxadispiro[5.2.5.2]hexadecane (5): yield,
90%; mp 130-131 °C (lit.26 mp 131-132 °C); 1H NMR 1.35-
1.51 (m, 4H), 1.52-1.72 (m, 12 H), 2.29 (br s, 4H); 13C NMR
21.94 (br s), 22.10 (br s), 25.38, 29.55 (br s), 31.77 (br s), 108.12.
X-ray Crystallographic Determinations. Single crystals
of tetraoxane derivatives 2 (methanol), 3 (ethanol), and 4
(methanol-hexane) were grown by slow evaporation from the
solvents indicated in parentheses. The X-ray diffraction data
(Mo KR ì ) 0.71073 Å) were collected on a Siemens P4
diffractometer at 160 K. The structures were solved by direct
methods and refined by full least-squares techniques using
anisotropic temperature factors for the non-hydrogen atoms.
All crystallographic calculations were carried out using the
SHELXTL suite of progams.27
Molecular Modeling Experiments. Molecular modeling
was done using PCModel by Serena Software, SYBYL by
Tripos Inc., Spartan by Wavefunction Inc., and Gaussian94
(revision A.1) by Gaussian Inc. MMX is a molecular mechanics
component of PCModel, and MM3 is a separate molecular
mechanics program from Tripos Inc. and is interfaced with
both Spartan and SYBYL. Using a systematic search technique








a Average of n g 2.
1248 Journal of Medicinal Chemistry, 2000, Vol. 43, No. 6 Brief Articles
as implemented in Spartan, the lowest energy and most
abundant tetraoxane conformers were selected for subsequent
ab initio 3-21G* calculations on Gaussian94. Molecular elec-
trostatic potential profiles were sampled over the entire
accessible surface of the tetraoxanes (van derWaals contact
to a distance of approximately 1.5 Å).
Antimalarial Screens. In vitro activity against P. falci-
parum was determined using a modification of the semiauto-
mated microdilution technique of Desjardins et al.28 and
Milhous et al.29 Two P. falciparum malaria parasite clones,
designated as Sierra Leone (D6) and Indochina (W2), were
used in susceptibility testing.30 The former is resistant to
mefloquine and the latter to CQ, pyrimethamine, sulfadoxine,
and quinine. Test compounds were dissolved in dimethyl
sulfoxide and solutions serially diluted with culture media.
Erythrocytes with 0.25-0.5% parasitemia were added to each
well of a 96-well microdilution plate to give a final hematocrit
of 1.5%. Inhibition of uptake of tritiated hypoxanthine was
used as an index of antimalarial activity. Results were initially
recorded as IC50 (ng/mL) values and then converted to nM
values.
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